Recent studies investigating the relationship between Trps1 and tumor malignancy have revealed reduced cellular expression levels of Trps1 at the primary sites of endometrial carcinoma and breast, prostate, pancreatic, and colon cancers [20–24]. This evidence concerns the gene TRPS1 and malignant colon neoplasm.